Description
Zidovudine Tablet
Zidovudine (AZT) Tablets 300 mg
Healthy Inc is a specialized global supplier and exporter of advanced infectious disease, immunology, and reproductive health therapeutics. We provide ultra-high-purity, kinetically stable Zidovudine Tablets, manufactured in WHO–GMP certified, high-precision antiretroviral manufacturing facilities. This “Nucleoside Reverse Transcriptase Inhibitor (NRTI)” is a high-volume strategic export to National AIDS Programs, NGO health missions, and international B2B distributors, serving as the globally preferred intervention for the management of HIV-1 infection and the prevention of vertical transmission.
Product Overview
This formulation operates as a “Genetic Chain Terminator.” It ensures patient safety by blocking the virus’s ability to convert its RNA into DNA, physically preventing the infection from spreading to new immune cells.
Mechanism 1 (Nucleoside Mimicry): Zidovudine is physically engineered to resemble Thymidine, a natural building block of DNA.
Mechanism 2 (Reverse Transcriptase Inhibition): The viral enzyme, Reverse Transcriptase, chemically mistakes Zidovudine for thymidine. Once the drug is physically incorporated into the growing viral DNA strand, it chemically prevents the attachment of further nucleotides.
Mechanism 3 (Viral Load Suppression): By physically halting DNA synthesis, it chemically stops the production of new viral particles, physically allowing the patient’s CD4 cell count to recover.
Product Composition & Strength
We supply this product in standardized strengths optimized for both monotherapy (in specific PMTCT cases) and combination therapy (HAART).
| Active Ingredient | Strength | Primary Clinical Target |
| Zidovudine IP/BP/USP | 300 mg | The Foundation: Standard dose for adult HIV management. |
| Excipients | Pharma Grade | The Matrix: Ensures shelf-life stability and rapid absorption. |
Technical & Logistics Specifications
HS Code: 3004.90.99 (Medicaments acting on infectious diseases / Antivirals)
CAS Number: 30516-87-1 (Zidovudine / AZT)
Dosage Form: Oral Tablet (Film-Coated)
Packaging: 10 Tablets per Blister or 60 Tablets per Bottle. We utilize high-barrier Alu-Alu or induction-sealed HDPE bottles to physically prevent moisture-induced degradation, ensuring 36-month stability in Zone IVb tropical climates.
Manufacturing Authority & Compliance
ARV Specialized Containment: Zidovudine is an active antiviral. Our manufacturing process utilizes Dedicated High-Containment Processing Suites, physically ensuring zero cross-contamination with other pharmaceutical classes.
Photo-Stability Engineering: Zidovudine is physically sensitive to light. We utilize Opaque Titanium Dioxide Film Coating, chemically ensuring the potency remains intact even in high-UV export regions.
Bioequivalence Accuracy: We utilize Advanced Dissolution Testing, physically ensuring our tablets are chemically bioequivalent to global innovator brands, a critical commercial requirement for NGO and Government tenders.
Primary Indications
Infectious Disease: Part of Highly Active Antiretroviral Therapy (HAART) for HIV-1 Infection.
Maternal Health: Prevention of Mother-to-Child Transmission (PMTCT) during pregnancy, labor, and delivery.
Occupational Health: Component of regimens for Post-Exposure Prophylaxis (PEP).
Usage Instructions
Administration: Swallow the tablet physically whole with water. It can be taken with or without food.
Consistency: It is physically critical to take the dose at the exact same time every day to chemically maintain stable viral suppression.
Adherence: Missing doses physically increases the risk of the virus developing Drug Resistance, chemically making future treatments less effective.
Safety Warning: For Professional Use Only. Hematologic Note: Zidovudine may physically cause Severe Anemia or Neutropenia; regular blood count monitoring is chemically mandatory. Lactic Acidosis: Rare but severe physical risk of lactic acidosis and hepatic steatosis. Contraindication: Do not use in patients with exceptionally low hemoglobin or neutrophil counts, or known hypersensitivity to Zidovudine.
Global Export & Contract Manufacturing
Healthy Inc is a premier Antiretroviral and Public Health Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume Zidovudine tablets. Whether you are a National Ministry of Health in Africa or a B2B Pharma Marketplace partner in the CIS or SE Asia, we ensure secure, WHO-GMP compliant delivery.
Commercial Inquiries:
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
